SPINEWAY Share Price Swiss Exchange
Equities
FR0011398874
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
04-17 | Spineway: punished despite a solid first quarter | CF |
04-16 | Spineway SA Announces Revenue Results for the First Quarter of 2024 | CI |
Sales 2022 | 8.53M 9.25M 722M | Sales 2023 | 11.36M 12.31M 961M | Capitalization | 499K 541K 42.24M |
---|---|---|---|---|---|
Net income 2022 | -3M -3.25M -254M | Net income 2023 | -6M -6.5M -508M | EV / Sales 2022 | - |
Net cash position 2022 | 4.08M 4.43M 346M | Net Debt 2023 | 814K 882K 68.87M | EV / Sales 2023 | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 2.55% |
Managers | Title | Age | Since |
---|---|---|---|
Stéphane Le Roux
CEO | Chief Executive Officer | 63 | 27/09/05 |
Director of Finance/CFO | - | 26/01/20 | |
Sandrine Carle
PRN | Corporate Officer/Principal | - | 11-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Weiguang Guo
BRD | Director/Board Member | 68 | - |
Stéphane Le Roux
CEO | Chief Executive Officer | 63 | 27/09/05 |
Joseph Brigneaud
BRD | Director/Board Member | 46 | 12/10/17 |
1st Jan change | Capi. | |
---|---|---|
-5.50% | 181B | |
-5.79% | 99.52B | |
-6.59% | 65.82B | |
-8.38% | 45.21B | |
+8.42% | 43.85B | |
+10.10% | 42.17B | |
+10.97% | 28.75B | |
+18.89% | 25.39B | |
-8.39% | 23.5B |